Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan

Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan

Chronic hepatitis C virus (HCV) infection is a major cause of morbidity and mortality in patients with hemophilia. However, the efficacy and safety of pegylated interferon (PEG-IFN) plus ribavirin (RBV) for hemophilic patients with chronic HCV infection in Taiwan are still unknown. The aim of this s...

Full description

Bibliographic Details
Main Authors: Jung-An Lin, Yeu-Chin Chen, Shin-Nan Cheng, Peng-Jen Chen, Heng-Cheng Chu, Tsai-Yuan Hsieh, Yu-Lueng Shih
Format: Article
Language:English
Published: Elsevier 2014-10-01
Series:Journal of the Formosan Medical Association
Subjects:
hemophilia
hepatitis C
pegylated interferon
ribavirin
viral response
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664613003653

Internet

http://www.sciencedirect.com/science/article/pii/S0929664613003653

Similar Items